Catalent | CTLT - Pendapatan Penjualan



Penjualan Perubahan Tanggal
Agilent USD 1.88B 43M 2026-06
AstraZeneca USD 15.38B 90M 2026-06
Bristol-Myers Squibb USD 12.97B 1.48B 2026-06
Bruker USD 838.5M 15.1M 2026-06
Centene USD 53.58B 3.64B 2026-06
Charles River Laboratories USD 1000M 4.2M 2026-06
Cigna USD 71.7B 3.18B 2026-06
Danaher USD 6.3B 350M 2026-06
Dentsply International USD 898M 18M 2026-06
Elevance Health USD 49.8B 300M 2026-06
Eli Lilly USD 22.97B 3.17B 2026-06
Glaxosmithkline GBP 10.09B 1.37B 2026-03
Humana USD 40.89B 1.24B 2026-06
Illumina USD 1.16B 70M 2026-06
Intuitive Surgical USD 2.89B 120M 2026-06
IQVIA Holdings USD 4.37B 220M 2026-06
J&J USD 25.31B 1.21B 2026-06
Laboratory Of America USD 3.73B 190M 2026-06
Lonza CHF 3.58B 63M 2025-06
McKesson USD 105.38B 13.08B 2026-06
Merck EUR 5.43B 300M 2026-06
Merck USD 16.6B 310M 2026-06
Mettler Toledo International USD 1.03B 82.87M 2026-06
Novartis USD 14.41B 1.3B 2026-06
Pfizer USD 15.03B 530M 2026-06
Quest Diagnostics USD 3.04B 140M 2026-06
Repligen USD 204M 10M 2026-06
Revvity USD 729.68M 18.68M 2026-06
Roche Holding CHF 30.36B 14.71B 2026-06
Supernus Pharmaceuticals USD 219.1M 11.39M 2026-06
Thermo Fisher Scientific USD 11.99B 980M 2026-06
UnitedHealth USD 112B 300M 2026-06
Veradigm USD 142.52M 9.38M 2022-12
Waters USD 1.64B 370M 2026-06
West Pharmaceutical Services USD 872.3M 27.4M 2026-06